IP Library Granted Patent US 7,462,689
Granted Patent B2
US 7,462,689 · App. 10/720,843 · Granted Dec 9, 2008

Hydrazine-based and carbonyl-based bifunctional crosslinking reagents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,462,689
App. No.
10/720,843
Granted
Dec 9, 2008
Kind
B2
Abstract

Reagents and methods are provided for crosslinking and immobilizing biomolecules, drugs and synthetic polymers. The reagents possess (i) a thiol or amino reactive group; and (ii) a hydrazino or oxyamino moiety. Conjugates and immobilized biomolecules are also provided.

Claims (41)

1. A compound of formula II:

B—R—A—NHN═C(R 1 R 2 )  II

or a derivative thereof, wherein:

A is NH(C═O)—, NH(C═S)—, NHNH(C═O)—, or NHNH(C═S)— or a direct bond to R;

B is an amino or thiol reactive moiety;

R is an aliphatic divalent group having any combination of the following groups, which are combined in any order: cycloalkylene, C(R 10 ) 2 , —C(R 10 )=C(R 10 )—, >C═C(R 12 )(R 13 ), >C(R 12 )(R 13 ), —C≡C—, O, S(G) a , P(J) b (R 10 ), P(J) b (LR 10 ), N(R 10 ), >N + (R 12 )(R 13 ) and C(L); where a is 0, 1 or 2; b is 0, 1, 2 or 3; G is O or NR 10 ; J is S or O; and L is S, O or NR 10 ; each R 10 is a monovalent group independently selected from hydrogen and M 1 -R 14 ; each M 1 is a divalent group independently having any combination of the following groups, which groups are combined in any order: a direct link, arylene, heteroarylene, cycloalkylene, C(R 15 ) 2 , —C(R 15 )═C(R 15 )—, >C═C(R 12 )(R 13 ), >C(R 12 )(R 13 ), —C≡C—, O, S(G 1 ) a , P(J) b (R 15 ), P(J) b (L 1 R 15 ), N(R 5 ), N(COR 15 ), >N + (R 12 )(R 13 ) and C(L 1 ); where a is 0, 1 or 2; b is 0, 1, 2 or 3; G 1 is O or NR 15 ; J is S or O; and L 1 is S, O or NR 15 ; R 14 and R 15 are each independently selected from the group among hydrogen, halo, pseudohalo, cyano, azido, nitro, SiR 16 R 17 R 18 , alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 19 R 20 ; R 19 and R 20 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl and heterocyclyl; R 12 and R 13 are selected from (i) or (ii) as follows: (i) R 12 and R 13 are independently selected from among hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl; or (ii) R 12 and R 13 together form alkylene, alkenylene or cycloalkylene; R 16 , R 17 and R 18 are each independently a monovalent group selected from hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 19 R 20 ; and

R 10 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 and R 20 can be substituted with one or more substituents each independently selected from Z, wherein Z is selected from alkyl, alkenyl, alkynyl, aryl, cycloalkyl, cycloalkenyl, hydroxy, S(O) h R 30 , NR 30 R 31 , COOR 30 , COR 30 , CONR 30 R 31 , OC(O)NR 30 R 31 , N(R 30 )C(O)R 31 , alkoxy, aryloxy, heteroaryl, heterocyclyl, heteroaryloxy, heterocyclyloxy, aralkyl, aralkenyl, aralkynyl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, aralkoxy, heteroaralkoxy, alkoxycarbonyl, carbamoyl, thiocarbamoyl, alkoxycarbonyl, carboxyaryl, halo, pseudohalo, haloalkyl and carboxamido; h is 0, 1 or 2; and R 30 and R 31 are each independently selected from among hydrogen, halo, pseudohalo, cyano, azido, nitro, trialkylsilyl, dialkylarylsilyl, alkyldiarylsilyl, triarylsilyl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy, amino, amido, alkylamino, dialkylamino, alkylarylamino, diarylamino and arylamino;

R 1 is a saturated straight chain of 3 to 20 carbon atoms, a chain of 2 to 2000 ethyleneoxide moieties, or a saturated or unsaturated carbocyclic moiety of 3 to 20 carbon atoms; and

R 2 is a saturated straight chain of 3 to 20 carbon atoms, a chain of 2 to 2000 ethyleneoxide moieties, or a saturated or unsaturated carbocyclic moiety of 3 to 20 carbon atoms.

2. A compound of formula II:

B—R—A—NHN═C(R 1 R 2 )  II

or a derivative thereof, wherein:

A is NH(C═O)—, NH(C═S)—, NHNH(C═O)—, or NHNH(C═S)— or a direct bond to R;

B is an amino or thiol reactive moiety;

R is a saturated straight chain of 1 to 20 carbon atoms, a chain of 2 to 2000 ethyleneoxide moieties, a saturated or an unsaturated carbocyclic moiety of 3 to 20 carbon atoms or an aliphatic divalent group having any combination of the following groups, which are combined in any order: cycloalkylene, C(R 10 ) 2 , —C(R 10 )=C(R 10 )—, >C═C(R 2 )(R 13 )>C(R 12 )(R 13 ), —C≡C—, O, S(G) a , P(J) b (R 10 ), P(J) b (LR 10 ), N(R 10 ), >N + (R 12 )(R 13 ) and C(L), where a is 0.1 or 2; b is 0, 1, 2 or 3; G is O or NR 10 ; J is S or O; and L is S, O or NR 10 ; each R 10 is a monovalent group independently selected from hydrogen and M 1 -R 14 ; each M 1 is a divalent group independently having any combination of the following groups, which groups are combined in any order: a direct link, arylene, heteroarylene, cycloalkylene, C(R 15 ) 2 —C(R 15 )═C(R 15 )—, >C═C(R 12 )(R 13 ), >C(R 12 )(R 13 ), —C≡C—, O, S(G 1 ) a , P(J) b (R 15 ), P(J) b (L 1 R 15 ), N(R 15 ), N(COR 15 ), >N + (R 12 )(R 13 ) and C(L 1 ); where a is 0, 1 or 2; b is 0, 1, 2 or 3; G 1 is O or NR 15 ; J is S or O; and L 1 is S, O or NR 15 ; R 14 and R 15 are each independently selected from the group among hydrogen, halo, pseudohalo, cyano, azido, nitro, SiR 16 R 17 R 18 , alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 19 R 20 ; R 19 and R 20 are each independently selected from hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl and heterocyclyl; R 12 and R 13 are selected from (i) or (ii) as follows: (i) R 12 and R 13 are independently selected from among hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl; or (ii) R 12 and R 13 together form alkylene, alkenylene or cycloalkylene; R 16 , R 17 and R 18 are each independently a monovalent group selected from hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy and NR 19 R 20 ; and

R 10 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 and R 20 can be substituted with one or more substituents each independently selected from Z, wherein Z is selected from alkyl, alkenyl, alkynyl, aryl, cycloalkyl, cycloalkenyl, hydroxy, S(O) h R 30 , NR 30 R 31 , COOR 30 , COR 30 , CONR 30 R 31 , OC(O)NR 30 R 31 , N(R 30 )C(O)R 30 , alkoxy, aryloxy, heteroaryl, heterocyclyl, heteroaryloxyn, heterocyclylox, aralkyl, aralkenyl, aralkynyl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, aralkoxy, heteroaralkoxy, alkoxycarbonyl, carbamoyl, thiocarbamoyl, alkoxycarbonyl, carboxyaryl, halo, pseudohalo, haloalkyl and carboxamido: h is 0, 1 or 2; and R 30 and R 31 are each independently selected from among hydrogen, halo, pseudohalo, cyano, azido, nitro, trialkylsilyl, dialkylarmlsilyl, alkyldiarylsilyl, triarylsilyl, alkyl, alkenyl, alkynyl, haloalkyl, haloalkoxy, aryl, aralkyl, aralkenyl, aralkynyl, heteroaryl, heteroaralkyl, heteroaralkenyl, heteroaralkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, hydroxy, alkoxy, aryloxy, aralkoxy, heteroaralkoxy, amino, amido, alkylamino, dialkylamino, alkylarylamino, diarylamino and arylamino;

R 1 is a saturated straight chain of 3 to 20 carbon atoms, a chain of 2 to 2000 ethyleneoxide moieties, or a saturated or unsaturated carbocyclic moiety of 3 to 20 carbon atoms; and

R 2 is a saturated straight chain of 3 to 20 carbon atoms, a chain of 2 to 2000 ethyleneoxide moieties, or a saturated or unsaturated carbocyclic moiety of 3 to 20 carbon atoms.

3. A compound of the formula:

4. A method of crosslinking a natural or synthetic biological molecule, comprising:

(i) preparing a conjugate of formula Va:

or a derivative thereof, wherein:

A is NH(C═O), NH(C═S), NH(C═NH), NHNH(C═O), NHNH(C═S), NHNH(C═NH) or a direct bond;

B is a natural or synthetic biological molecule;

D is a carbon or nitrogen atom;

E is a carbon or nitrogen atom;

R 1 is hydrogen or a saturated straight chain of 1 to 12 carbon atoms; and

R 2 is hydrogen or a saturated straight chain of 1 to 12 carbon atoms; and

(ii) applying the conjugate to a surface wherein the surface has at least one carbonyl moiety for a time and under conditions such that the hydrazine moiety of the conjugate reacts with the carbonyl moiety of the surface forming a hydrazone bond thereby crosslinking the natural or synthetic biological molecule to the surface.

5. A method of crosslinking a natural or synthetic biological molecule, comprising:

(i) preparing a conjugate of formula Va:

or a derivative thereof, wherein:

A is NH(C═O), NH(C═S), NH(C═NH), NHNH(C═O), NHNH(C═S), NHNH(C═NH) or a direct bond;

B is a natural or synthetic biological molecule;

D is a carbon or nitrogen atom;

E is a carbon or nitrogen atom;

R 1 is hydrogen or a saturated straight chain of 1 to 12 carbon atoms; and

R 2 is hydrogen or a saturated straight chain of 1 to 12 carbon atoms; and

(ii) mixing the conjugate with a second natural or synthetic biological molecule, wherein the second natural or synthetic biological molecule has at least one carbonyl moiety, for a time and under conditions such that the hydrazine moiety of the conjugate reacts with the carbonyl moiety of the second natural or synthetic biological molecule forming a hydrazone bond thereby crosslinking the natural or synthetic biological molecule to the second natural or synthetic biological molecule.

6. The compound of claim 1 , wherein B is an amino reactive moiety selected from succininimidyl ester, hydroxybenzotriazolyl ester, or pentafluorophenol ester.

7. The compound of claim 1 , wherein B is a thiol reactive moiety selected from maleimido, α-bromoacetyl, α-bromoacetamido or pyridyldisulfide.

Assignments (18)
SECURITY INTEREST Recorded Jun 7, 2024
From: VECTOR LABORATORIES, INC.
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 067659/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2021
From: TRILINK BIOTECHNOLOGIES, LLC
To: VECTOR LABORATORIES, INC.
Reel/Frame 057742/0627 →
SECURITY INTEREST Recorded Oct 7, 2021
From: VECTOR LABORATORIES, INC.
To: AUDAX PRIVATE DEBT LLC, AS AGENT
Reel/Frame 057729/0126 →
PARTIAL RELEASE OF SECURITY INTEREST Recorded Sep 2, 2021
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 057480/0783 →
RELEASE OF FIRST LIEN SECURITY INTEREST Recorded Oct 19, 2020
From: JPMORGAN CHASE BANK, N.A.
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0751 →
RELEASE OF SECOND LIEN SECURITY INTEREST Recorded Oct 19, 2020
From: ANTARES CAPITAL LP
To: VECTOR LABORATORIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH, LLC
Reel/Frame 054118/0763 →
SECURITY AGREEMENT Recorded Oct 19, 2020
From: MARAVAI LIFE SCIENCES, INC.; TRILINK BIOTECHNOLOGIES, LLC; VECTOR LABORATORIES, INC.; GLEN RESEARCH, LLC; CYGNUS TECHNOLOGIES, LLC; MOCKV SOLUTIONS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 054118/0848 →
RELEASE AND REASSIGNMENT OF SECURITY INTEREST RECORDED AT REEL/FRAME 40791/0639 Recorded Sep 13, 2018
From: NXT CAPITAL, LLC
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 047073/0142 →
SECURITY AGREEMENT Recorded Aug 3, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: ANTARES CAPITAL LP, AS COLLATERAL AGENT
Reel/Frame 046702/0651 →
SECURITY AGREEMENT Recorded Aug 2, 2018
From: TRILINK BIOTECHNOLOGIES; TRILINK BIOTECHNOLOGIES, INC.; TRILINK BIOTECHNOLOGIES, LLC; GLEN RESEARCH CORPORATION
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 046708/0095 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2016
From: SOLULINK INCORPORATED
To: TRILINK BIOTECHNOLOGIES, LLC
Reel/Frame 040810/0576 →
RELEASE OF SECURITY INTERESTS RECORDED AT REEL/FRAME 027370/0349, REEL/FRAME 030839/0673 AND REEL/FRAME 037218/0243 Recorded Dec 30, 2016
From: PLYMOUTH MANAGEMENT COMPANY; YOUNG, WALTER R, JR
To: SOLULINK INCORPORATED
Reel/Frame 041225/0221 →
SECURITY INTEREST Recorded Dec 28, 2016
From: TRILINK BIOTECHNOLOGIES, LLC
To: NXT CAPITAL, LLC, AS AGENT
Reel/Frame 040791/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2016
From: SCHWARTZ, DAVID A.
To: SOLULINK, INCORPORATED
Reel/Frame 040653/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2015
From: PLYMOUTH MANAGEMENT COMPANY; YOUNG, WALTER R.
To: SOLULINK, INCORPORATED
Reel/Frame 037218/0243 →
SECURITY INTEREST Recorded Jul 15, 2013
From: SOLULINK INCORPORATED
To: PLYMOUTH MANAGEMENT COMPANY, AS AGENT AND WALTER R. YOUNG, JR., AS AGENT
Reel/Frame 030839/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2011
From: SOLULINK, INCORPORATED
To: PLYMOUTH MANAGEMENT COMPANY AS AGENT FOR INVESTORS; YOUNG, JR., WALTER R.
Reel/Frame 027370/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2008
From: SCHWARTZ, DAVID A.
To: SOLULINK BIOSCIENCES, INC.
Reel/Frame 021797/0926 →